Literature DB >> 22994760

Follow-up study of survival of patients with advanced cancer in a hospice setting.

Yu-Mei Wang1, Hai-Qiang Guo.   

Abstract

OBJECTIVE: This study was to present the survival of advanced cancer patients and explore the influence of various factors on survival time as well as survival rate. The results provide guidelines for clinical practice of cancer treatment.
METHODS: Follow-up of 674 advanced cancer patients was performed in a hospice. The median survival time and survival rate were calculated, and survival analysis was carried out.
RESULTS: The median survival time of all patients dying from cancer was 12.0 months and the average survival time was 25.1 months. The 1-year cumulative survival rate was 0.518±0.020 and the 5-year cumulative survival rate was 0.088±0.012. The following factors showed significant impacts on survival rate: gender, age, primary diagnosis, surgery and the time when pain appeared.
CONCLUSIONS: The survival time of patients with advanced cancer was relatively short. Major approaches to extend the survival time include early detection, early diagnosis, effective surgical treatment, pain control, reasonable supply of nutrients and multiple interventions.

Entities:  

Mesh:

Year:  2012        PMID: 22994760     DOI: 10.7314/apjcp.2012.13.7.3357

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  2 in total

1.  Five-Year Survival is Not a Useful Measure for Cancer Control in the Population: an Analysis Based on UK Data

Authors:  Si Qi Li; Xiong Fei Pan; Michael Saheb Kashaf; Qing Ping Xue; Hui Jing Luo; Yan Yan Wang; Ying Wen; Chun Xia Yang
Journal:  Asian Pac J Cancer Prev       Date:  2017-02-01

2.  A non-lab nomogram of survival prediction in home hospice care patients with gastrointestinal cancer.

Authors:  Muqing Wang; Xubin Jing; Weihua Cao; Yicheng Zeng; Chaofen Wu; Weilong Zeng; Wenxia Chen; Xi Hu; Yanna Zhou; Xianbin Cai
Journal:  BMC Palliat Care       Date:  2020-12-07       Impact factor: 3.234

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.